Prosthetic Valve Endocarditis Five Months following Transcatheter Aortic Valve Implantation and Review of Literature

Authors

  • Siyamek Neragi-Miandoab Department of Cardiovascular and Thoracic Surgery, New England Heart Institute, Catholic Medical Center, Manchester, New Hampshire
  • Benjamin Westbrook Department of Cardiovascular and Thoracic Surgery, New England Heart Institute, Catholic Medical Center, Manchester, New Hampshire
  • James Flynn Department of Cardiology, New England Heart Institute, Catholic Medical Center, Manchester, New Hampshire
  • Jeffrey Blakely Department of Cardiology, New England Heart Institute, Catholic Medical Center, Manchester, New Hampshire
  • Yvon Baribeau Department of Cardiovascular and Thoracic Surgery, New England Heart Institute, Catholic Medical Center, Manchester, New Hampshire

DOI:

https://doi.org/10.1532/hsf.1221

Abstract

There are only a few cases of prosthetic valve endocarditis (PVE) following transcatheter aortic valve implantation (TAVI) reported in the literature. Though not very frequent, this is a serious concern because patients are high risk for surgical aortic valve replacement (SAVR) by definition, and explanting the endocarditic prosthetic valve followed by SAVR increases risk even higher.

Published

2015-04-06

How to Cite

Neragi-Miandoab, S., Westbrook, B., Flynn, J., Blakely, J., & Baribeau, Y. (2015). Prosthetic Valve Endocarditis Five Months following Transcatheter Aortic Valve Implantation and Review of Literature. The Heart Surgery Forum, 18(1), E020-E022. https://doi.org/10.1532/hsf.1221

Issue

Section

Articles